Veradermics, Inc
MANENYSECIK 1827635HealthcareFiscal year ends Dec 31
Reports and events: 24 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1913:06 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001827635-26-000036 |
| 2026-08-2122:32 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000899140-26-000948 |
| 2026-08-1400:00 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001072613-26-000686 |
| 2026-08-1120:38 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001827635-26-000030 |
| 2026-08-1112:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001827635-26-000028 |
| 2026-08-0721:08 ET | S-1 | Registration statement | 0001628280-26-054921 |
| 2026-07-1512:54 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001827635-26-000023 |
| 2026-05-1221:06 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001827635-26-000019 |
| 2026-05-1212:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001827635-26-000016 |
| 2026-05-0501:39 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000899140-26-000416 |
| 2026-05-0501:07 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-26-207186 |
| 2026-05-0523:44 ET | SCHEDULE 13D | Ownership report, active investor | 0001013594-26-000528 |
| 2026-05-0120:35 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001628280-26-029376 |
| 2026-04-2721:18 ET | S-1 | Registration statement | 0001628280-26-027631 |
| 2026-04-2721:16 ET | 8-K | 2.02 Results of operations | 0001628280-26-027629 |
| 2026-04-2713:10 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-027354 |
| 2026-03-3021:35 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001827635-26-000013 |
| 2026-03-3012:44 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001827635-26-000010 |
| 2026-02-1223:11 ET | SCHEDULE 13D | Ownership report, active investor | 0001193125-26-049157 |
| 2026-02-1122:22 ET | SCHEDULE 13D | Ownership report, active investor | 0000899140-26-000173 |
| 2026-02-1121:29 ET | SCHEDULE 13D | Ownership report, active investor | 0001193125-26-046658 |
| 2026-02-0521:21 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001628280-26-005800 |
| 2026-01-2816:52 ET | S-1/A | Registration statement, amended | 0001628280-26-003764 |
| 2026-01-0922:04 ET | S-1 | Registration statement | 0001628280-26-001651 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.